Net Income

A new report shows fraud fears in private credit are soaring, fueled by AI and bankruptcies, but data reveals a different story for secured lenders.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

Creality's new Sermoon P1 combines standalone processing and multi-mode lasers, offering industrial-grade 3D scanning at a disruptive price point.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

With its SMA drug stalled by a factory inspection, Scholar Rock secures major financing and signals a clear path to a transformative market debut in 2026.

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

A new report reveals Canadians are overwhelmed by scams, making them vulnerable to AI-driven fraud. Is a national strategy enough to fight back?

A major renewal with a 30M-client bank highlights the industry's shift to biometrics, boosting BIO-key's finances and solidifying its market niche.

The caller ID giant is expanding its ad business into Africa, MENA, and Asia, a move to diversify revenue and tap into booming mobile-first economies.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.

MAIA Biotechnology secured a crucial $30M to advance its promising lung cancer drug, but the move sent its stock plunging amid investor fears of dilution.

The AI firm reports a major financial overhaul and key acquisitions, but faces declining revenue and operational losses. Is it poised for a 2026 rebound?

LendingTree posts a record $319.7M Q4 driven by its insurance arm, yet an adjusted loss spooks investors. Can its AI-powered strategy win them back?

Applied Digital seeks massive debt to build a new AI factory, a high-stakes gamble in the race to power the future of artificial intelligence.

James River Group flips a $94M loss to a $30.1M profit, driven by strategic underwriting, cost cuts, and a pivotal move from Bermuda to Delaware.

Joseph Ruhl's promotion to Senior EVP signals Orange Bank & Trust's aggressive push for market share in the competitive Hudson Valley region.

As retail crime costs Canadians billions, the RCC awards its top loss prevention leaders who are fighting back with innovation and new technology.

Century-old insurer CopperPoint hires cybersecurity founder Thomas Beale as CIO, signaling an aggressive push to accelerate its tech transformation.

The trans-pacific merger between US BioTek and Australia's NutriPATH creates a major new force in functional medicine, promising expanded global access.